Compare ARK Genomic Revolution ETF (ARKG) vs Schlumberger NV (SLB) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
ARK Genomic Revolution ETF vs Schlumberger NV — how do they compare? ARK Genomic Revolution ETF trades at $44.36, while Schlumberger NV trades at $53.7 (market cap $79.67B). The key difference: Schlumberger NV pays a 2.2% dividend while ARK Genomic Revolution ETF pays none, and ARK Genomic Revolution ETF is trading nearer its 52-week high, Schlumberger NV nearer its low. Which is the better fit depends on your goals.
| ARKG | SLB | |
|---|---|---|
Sector | Sector/Thematic | Energy |
52-Week High | $44.55 | $58.01 |
52-Week Low | $24.02 | $31.72 |
Market Cap | — | $79.67B |
Enterprise Value | — | $88.40B |
Dividend Yield | — | 2.2% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About ARK Genomic Revolution ETF
ARKG is an actively managed ETF that invests in the genomic revolution. It focuses on companies leading in gene editing, CRISPR technology, therapeutics, and molecular diagnostics, including firms like CRISPR Therapeutics and Tempus AI.
Read more on ARKG →About Schlumberger NV
Schlumberger is the largest oilfield service firm in the world, with expertise in myriad disciplines, including reservoir performance, well construction, production enhancement, and more recently, digital solutions. It maintains a reputation as one of the industry's leading innovators, which has earned it dominant share in numerous end markets.
Read more on SLB →
